This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jiang, W. Articles by Mirochnitchenko, O. Search for Related Content PubMed PubMed Citation Articles by Jiang, W. Articles by Mirochnitchenko, O.

IRIP, a New Ischemia/Reperfusion-Inducible Protein That Participates in the Regulation of Transporter Activity

Wei Jiang, Olga Prokopenko, Lawrence Wong, Masayori Inouye, and Oleg Mirochnitchenko^*

Department of Biochemistry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854

Received 25 February 2005/ Returned for modification 16 March 2005/ Accepted 12 May 2005

We report the identification and characterization of a new ischemia/reperfusion-inducible protein (IRIP), which belongs to the SUA5/YrdC/YciO protein family. IRIP cDNA was isolated in a differential display analysis of an ischemia/reperfusion-treated kidney RNA sample. Mouse IRIP mRNA was expressed in all tissues tested, the highest level being in the testis, secretory, and endocrine organs. Besides ischemia/reperfusion, endotoxemia also activated the expression of IRIP in the liver, lung, and spleen. The transporter regulator RS1 was identified as an IRIP-interacting protein in yeast two-hybrid screening. The interaction between IRIP and RS1 was further confirmed in coimmunoprecipitation assays. A possible role of IRIP in regulating transporter activity was subsequently investigated. IRIP overexpression inhibited endogenous 1-methyl-4-phenylpyridinium (MPP⁺) uptake activity in HeLa cells. The activities of exogenous organic cation transporters (OCT2 and OCT3), organic anion transporter (OAT1), and monoamine transporters were also inhibited by IRIP. Conversely, inhibition of IRIP expression by small interfering RNA or antisense RNA increased MPP⁺ uptake. We measured transport kinetics of OCT2-mediated uptake and demonstrated that IRIP overexpression significantly decreased V_max but did not affect K_m. On the basis of these results, we propose that IRIP regulates the activity of a variety of transporters under normal and pathological conditions.

Present address: Undergraduate program, Rutgers University, Piscataway, NJ 08854.

This article has been cited by other articles:

• Vernaleken, A., Veyhl, M., Gorboulev, V., Kottra, G., Palm, D., Burckhardt, B.-C., Burckhardt, G., Pipkorn, R., Beier, N., van Amsterdam, C., Koepsell, H. (2007). Tripeptides of RS1 (RSC1A1) Inhibit a Monosaccharide-dependent Exocytotic Pathway of Na+-D-Glucose Cotransporter SGLT1 with High Affinity. J. Biol. Chem. 282: 28501-28513 [Abstract] [Full Text]  
• Kroiss, M., Leyerer, M., Gorboulev, V., Kuhlkamp, T., Kipp, H., Koepsell, H. (2006). Transporter regulator RS1 (RSC1A1) coats the trans-Golgi network and migrates into the nucleus. Am. J. Physiol. Renal Physiol. 291: F1201-F1212 [Abstract] [Full Text]  
• Veyhl, M., Keller, T., Gorboulev, V., Vernaleken, A., Koepsell, H. (2006). RS1 (RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1. Am. J. Physiol. Renal Physiol. 291: F1213-F1223 [Abstract] [Full Text]